TREATMENT OF YOUNG CHILDREN WITH DISSEMINATED MEDULLOBLASTOMA WITHIN THE PROSPECTIVE MULTICENTER TRIAL HIT 2000

被引：0

作者：

Friedrich, Carsten ^{[1
]}

von Bueren, Andre O. ^{[1
]}

von Hoff, Katja ^{[1
]}

Gerber, Nicolas U. ^{[2
]}

Benesch, Martin ^{[3
]}

Faldum, Andreas ^{[4
]}

Pietsch, Torsten ^{[5
]}

Warmuth-Metz, Monika ^{[6
]}

Kuehl, Joachim ^{[7
]}

Kortmann, Rolf D. ^{[8
]}

Rutkowski, Stefan ^{[1
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany

[2] Univ Childrens Hosp, Dept Oncol, Zurich, Switzerland

[3] Med Univ Graz, Div Pediat Hematol & Oncol, Dept Pediat & Adolescent Med, Graz, Austria

[4] Univ Munster, Inst Biostat & Clin Res, Munster, Germany

[5] Univ Bonn, Dept Neuropathol, Bonn, Germany

[6] Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany

[7] Univ Wurzburg, Dept Pediat Oncol, Wurzburg, Germany

[8] Univ Leipzig, Dept Radiat Oncol, Leipzig, Germany

来源：

NEURO-ONCOLOGY | 2012年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：91 / 91

页数：1

共 50 条

[21] Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Mynarek, Martin
von Hoff, Katja
Pietsch, Torsten
Ottensmeier, Holger
Warmuth-Metz, Monika
Bison, Brigitte
Pfister, Stefan
Korshunov, Andrey
Sharma, Tanvi
Jaeger, Natalie
Ryzhova, Marina
Zheludkova, Olga
Golanov, Andrey
Rushing, Elisabeth Jane
Hasselblatt, Martin
Koch, Arend
Schueller, Ulrich
von Deimling, Andreas
Sahm, Felix
Sill, Martin
Riemenschneider, Markus J.
Dohmen, Hildegard
Monoranu, Camelia Maria
Sommer, Clemens
Staszewski, Ori
Mawrin, Christian
Schittenhelm, Jens
Brueck, Wolfgang
Filipski, Katharina
Hartmann, Christian
Meinhardt, Matthias
Pietschmann, Klaus
Haberler, Christine
Slavc, Irene
Gerber, Nicolas U.
Grotzer, Michael
Benesch, Martin
Schlegel, Paul Gerhardt
Deinlein, Frank
von Bueren, Andre O.
Friedrich, Carsten
Juhnke, Bjoern-Ole
Obrecht, Denise
Fleischhack, Gudrun
Kwiecien, Robert
Faldum, Andreas
Kortmann, Rolf Dieter
Kool, Marcel
Rutkowski, Stefan
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (18) : 2028 - +
[22] LONG TERM NEUROPSYCHOLOGICAL FOLLOW UP OF YOUNG CHILDREN WITH MEDULLOBLASTOMA AND EPENDYMOMA TREATED IN THE TRIALS HIT-SKK'87/'92 AND HIT 2000
Ottensmeier, H.
Frahsek, S.
Faldum, A.
Rutkowski, S.
NEURO-ONCOLOGY, 2010, 12 (06) : II13 - II13
[23] QUALITY ASSURANCE IN CEREBROSPINAL FLUID CYTOLOGY ASSESSMENT FOR MEDULLOBLASTOMA STAGING LEADS TO POTENTIAL IMPROVED RISK-GROUP ASSESSMENT IN THE PROSPECTIVE MULTICENTER HIT-2000 TRIAL
Hagel, Christian
Sloman, Veronika
Mynarek, Martin
Petrasch, Katharina
Obrecht, Denise
Deinlein, Frank
Schmid, Renate
von Bueren, Andre O.
Friedrich, Carsten
Juhnke, B. Ole
Gerber, Nicolas U.
Kwiecien, Robert
Girschick, Hermann
Hoeller, Alexandra
Zapf, Antonia
von Hoff, Katja
Rutkowski, Stefan
NEURO-ONCOLOGY, 2020, 22 : 425 - 426
[24] HIT-SKK2000: BEHAVIORAL AND FUNCTIONAL PROBLEMS OF YOUNG CHILDREN WITH MEDULLOBLASTOMA AND EPENDYMOMA 5 YEARS AFTER DIAGNOSIS
Frahsek, S.
Rutkowski, S.
Faldum, A.
Ottensmeier, H.
NEURO-ONCOLOGY, 2010, 12 (06) : II76 - II76
[25] Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma:: Results of patients treated in the prospective multicenter trial HIT'91
Rutkowski, S.
von Hoff, K.
von Bueren, A.
Shalaby, T.
Hartmann, W.
Deinlein, F.
Warmuth-Metz, M.
Soerensen, N.
Faldum, A.
Bode, U.
Mittler, U.
Urban, C.
Benesch, M.
Kortmann, R. D.
Schlegel, P. G.
Kuehl, J.
Pietsch, T.
Grotzer, M.
NEURO-ONCOLOGY, 2007, 9 (02) : 191 - 191
[26] Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91 - Implications for investigating childhood medulloblastoma
Grotzer, M. A.
von Hoff', K.
Shalaby, T.
Hartmann, W.
Warmuth-Metz, M.
Emser, A.
Kortmann, R. D.
Kueh, J.
Pietsch, T.
Rutkowski, S.
KLINISCHE PADIATRIE, 2007, 219 (06): : 312 - 317
[27] Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial
Dietzsch, Stefan
Placzek, Felix
Pietschmann, Klaus
von Bueren, Andre O.
Matuschek, Christiane
Glueck, Albrecht
Guckenberger, Matthias
Budach, Volker
Welzel, Jutta
Poettgen, Christoph
Schmidberger, Heinz
Heinzelmann, Frank
Paulsen, Frank
Escudero, Montserrat Pazos
Schwarz, Rudolf
Hornung, Dagmar
Martini, Carmen
Grosu, Anca Ligia
Stueben, Georg
ablonska, Karolina J.
Dunst, Juergen
Stranzl-Lawatsch, Heidi
Dieckmann, Karin
Timmermann, Beate
Pietsch, Torsten
Warmuth-Metz, Monika
Bison, Brigitte
Kwiecien, Robert
Benesch, Martin
Gerber, Nicolas U.
Grotzer, Michael A.
Pfister, Stefan M.
Clifford, Steven C.
von Hoff, Katja
Klagges, Sabine
Rutkowski, Stefan
Kortmann, Rolf-Dieter
Mynarek, Martin
ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (06) : 1158 - 1169
[28] Towards a better clinicobiological risk stratification system in childhood medulloblastoma:: results of patients treated in the prospective multicenter trial HIT'91
von Bueren, A.
von Hoff, K.
Pietsch, T.
Rutkowski, S.
Grotzer, M. A.
SWISS MEDICAL WEEKLY, 2006, 136 : 14S - 14S
[29] Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: Results of patients treated in the prospective multicenter trial HIT'91
Rutkowski, Stefan
von Bueren, Andre
von Hoff, Katja
Hartmann, Wolfgang
Shalaby, Tarek
Deinlein, Frank
Warmuth-Metz, Monika
Soerensen, Niels
Emser, Angela
Bode, Udo
Mittler, Uwe
Urban, Christian
Benesch, Martin
Kortmann, Rolf D.
Schlegel, Paul G.
Kuehl, Joachim
Pietsch, Torsten
Grotzer, Michael
CLINICAL CANCER RESEARCH, 2007, 13 (09) : 2651 - 2657
[30] YOUNG CHILDREN WITH METASTATIC MEDULLOBLASTOMA: FREQUENT REQUIREMENT FOR RADIOTHERAPY IN CHILDREN WITH NON-WNT/NON-SHH MEDULLOBLASTOMA DESPITE HIGHLY INTENSIFIED CHEMOTHERAPY - RESULTS OF THE MET-HIT2000-BIS4 TRIAL
Mynarek, Martin
Goschzik, Tobias
Kool, Marcel
von Hoff, Katja
Ottensmeier, Holger
Warmuth-Metz, Monika
Bison, Brigitte
Sill, Martin
Rushing, Elisabeth Jane
Hasselblatt, Martin
Koch, Arend
Schueller, Ulrich
von Deimling, Andreas
Riemenschneider, Markus J.
Dohmen, Hildegard
Monoranu, Camelia-Maria
Sommer, Clemens
Staszewski, Ori
Mawrin, Christian
Schittenhelm, Jens
Bruck, Wolfgang
Filipski, Katharina
Hartmann, Christian
Meinhardt, Matthias
Pietschmann, Klaus
Haberler, Christine
Slavc, Irene
Gerber, Nicolas U.
Grotzer, Michael
Benesch, Martin
Schlegel, Paul-Gerhardt
Deinlein, Frank
Bode, Udo
von Bueren, Andre O.
Friedrich, Carsten
Obrecht, Denise
Fleischhack, Gudrun
Kwiecien, Robert
Faldum, Andreas
Kortmann, Rolf-Dieter
Pietsch, Torsten
Pfister, Stefan
Rutkowski, Stefan
NEURO-ONCOLOGY, 2022, 24 : 104 - 104

← 1 2 3 4 5 →